Evaluation of Evidence-Based Dual Antiplatelet Therapy for Secondary Prevention in US Patients With Acute Ischemic Stroke.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 35344009.
- Also identified by DOI 10.1001/jamainternmed.2022.0323 and PMC identifier 8961397.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cohort study examines patterns in prescriptions of dual antiplatelet therapy after publication of important trials and release of updated guidelines.
Medical subject headings
- Ischemic Attack, Transient
- Ischemic Stroke
- Stroke